AbbVie Inc. CDR (ABBV)
TSX
Closed
Aug 25, 2026
Day's Range
36.7952 wk Range
26.89Overview - ABBV - AbbVie Inc. CDR
Key Statistics
Valuation
Enterprise Value
708.55B
P/E (Trailing)
‪71.23‬
PEG Ratio
‪0.25‬
Price / Sales (TTM)
‪10.56‬
Price / Book
‪-105.15‬
EV / EBITDA
‪31.20‬
Profitability
Gross Margin
‪74.74%‬
Profit Margin
‪70.23%‬
Operating Margin
‪15.51%‬
Return on Assets
‪3.12%‬
Return on Equity
‪-129.67%‬
Ownership
Shares Outstanding
1.76B
Price stats
50-Day Avg
‪34.54‬
200-Day Avg
‪31.81‬
Dividends
Frequency
Quarterly
Shariah Compliance
Report Date: Feb 18, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - ABBV - AbbVie Inc. CDR
Peers - ABBV - AbbVie Inc. CDR
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on TSX.
Profile Summary - ABBV - AbbVie Inc. CDR
About
AbbVie Inc. CDR is a Canadian Depositary Receipt that provides Canadian investors with exposure to AbbVie Inc., a research-based biopharmaceutical company, trading in Canadian dollars with a currency hedge to minimize foreign exchange risk. AbbVie Inc. engages in the discovery, development, manufacturing, and sale of…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
